Radiomic and dosiomic prediction of biochemical failure after Iodine-125 prostate brachytherapy

被引：0

作者：

Nakano, M. ^{[1
]}

Ishiyama, H. ^{[1
]}

Kawakami, S. ^{[1
]}

Sekiguchi, A. ^{[1
]}

Kainuma, T. ^{[1
]}

Tsumura, H. ^{[2
]}

Hashimoto, M. ^{[3
]}

Hasegawa, T. ^{[3
]}

Tanaka, Y. ^{[4
]}

Katakura, T. ^{[4
]}

Murakami, Y. ^{[5
]}

机构：

[1] Kitasato Univ, Dept Radiat Oncol, Sch Med, Sagamihara, Kanagawa, Japan

[2] Kitasato Univ, Dept Urol, Sch Med, Sagamihara, Kanagawa, Japan

[3] Kitasato Univ, Sch Allied Hlth Sci, Dept Med Engn & Technol, Sagamihara, Kanagawa, Japan

[4] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa, Japan

[5] Canc Inst Hosp, Dept Radiat Oncol, Koto Ku, Tokyo, Japan

来源：

RADIOTHERAPY AND ONCOLOGY | 2022年 / 170卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PO-1788

引用

页码：S1595 / S1596

页数：2

共 50 条

[1] A prediction model for biochemical failure after salvage Iodine-125 prostate brachytherapy
Peters, M.
van Zyp, J. R. N. Van der Voort
Moerland, M. A.
Hoekstra, C. J.
Van de Pol, S.
Westendorp, H.
Maenhout, M.
Kattevilder, R.
Verkooijen, H. M.
Van Rossum, P. S. N.
Ahmed, H. U.
Shah, T.
Emberton, M.
Van Vulpen, M.
RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S28 - S29
[2] Dosiomic predictors of biochemical failure in patients with localized prostate cancer treated with Iodine-125 low-dose-rate brachytherapy
Masahiro Nakano
Shizuo Kaji
Shogo Kawakami
Hideyasu Tsumura
Toshikazu Imae
Yuichi Tanaka
Kyohei Fujii
Takuro Kainuma
Ryosuke Yamazaki
Ayaka Uchida
Hijiri Kaneko
Mako Fujino
Chizu Hata
Yu Murakami
Masatoshi Hashimoto
Hiromichi Ishiyama
Radiation Oncology, 20 (1)
[3] The impact of perineural invasion on biochemical outcome after permanent prostate iodine-125 brachytherapy
Pina, Alfonso Gomez-Iturriaga
Crook, Juanita Mary
Kwan, Paul
Borg, Jette
Ma, Clement
BRACHYTHERAPY, 2010, 9 (03) : 213 - 218
[4] Iodine-125 seed prostate brachytherapy: seed prediction and class solutions
Lau, Y. G. J.
Al-Qaisieh, B.
Wright, G.
Brearley, E.
Mason, J.
Bownes, P.
RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S334 - S334
[5] Development and internal validation of a multivariable prediction model for biochemical failure after whole-gland salvage iodine-125 prostate brachytherapy for recurrent prostate cancer
Peters, M.
van Zyp, J. R. N. van der Voort
Moerland, M. A.
Hoekstra, C. J.
van de Pol, S.
Westendorp, H.
Maenhout, M.
Kattevilder, R.
Verkooijen, H. M.
van Rossum, P. S. N.
Ahmed, H. U.
Shah, T. T.
Emberton, M.
van Vulpen, M.
BRACHYTHERAPY, 2016, 15 (03) : 296 - 305
[6] PSA bounce and biochemical failure analysis in low dose rate iodine-125 prostate brachytherapy boost
Bulto Boque, N.
Goni Ramirez, A.
de Paula Carranza, B.
Saenz de Urturi Albisu, E. M.
Pagola Divasson, M.
Ortiz de Urbina Ugarte, D. I.
Rosa Nieto, J.
Ayete Andreu, A.
Erzilbengoa Izaguirre, M.
Pastor Sanchis, V.
Bartres Salido, A.
Suarez Alvarez, N.
RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1135 - S1136
[7] Expansion and regression of prostate volume after permanent brachytherapy with iodine-125
Messer, PM
Goufried, HW
Schneider, E
Waletzko, O
Hautmann, R
Röttinger, EM
STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 42 - 42
[8] PSA PROFILE OF CURED PATIENTS AFTER IODINE-125 PROSTATE BRACHYTHERAPY
Crook, J.
Gomez, A.
Ma, C.
McLean, M.
Fung, S.
RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S7 - S8
[9] Calibration Seed Sampling for Iodine-125 Prostate Brachytherapy
Crowe, Scott
Kairn, Tanya
WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING 2018, VOL 3, 2019, 68 (03): : 459 - 462
[10] A nalysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
Du, E.
Wang, Lin
Li, Chang-ying
Zhang, Chang-wen
Qu, Yan-chun
Liu, Ran-lu
Xu, Yong
Yang, Kuo
Zhang, Zhi-hong
ONCOTARGETS AND THERAPY, 2017, 10 : 2561 - 2567

← 1 2 3 4 5 →